DNTH•United States•Healthcare•United States•$3.37B

Stocks Similar to DNTH

Top 20 stocks similar to Dianthus Therapeutics Inc. based on sector, industry, market cap, and valuation multiples. Same-industry peers (Biotechnology) are ranked first.

Company	Industry	Market Cap	P/E	Yield	Change	Compare
30 Yili Chuanning Biotechnology Co. Ltd. A 301301 • China	Biotechnology	$3.37B	30.3	1.65%	-2.03%	vs
CO Corcept Therapeutics Incorporated CORT • United States	Biotechnology	$3.42B	39.2	—	+0.89%	vs
BI BB Biotech AG BION • Switzerland	Biotechnology	$3.30B	4.4	4.88%	-2.03%	vs
BB BB Biotech AG BBZA • Germany	Biotechnology	$3.29B	0.0	4.52%	-0.99%	vs
DN Denali Therapeutics Inc DNLI • United States	Biotechnology	$3.26B	0.0	—	-1.56%	vs
96 Duality Biotherapeutics Inc 9606 • Hong Kong	Biotechnology	$3.48B	0.0	—	-0.19%	vs
TL TELIX Pharmaceuticals Ltd TLX • Australia	Biotechnology	$3.48B	0.0	—	-2.19%	vs
AC ACADIA Pharmaceuticals Inc ACAD • United States	Biotechnology	$3.51B	9.0	—	+0.32%	vs
68 BrightGene Bio Medical Technology C 688166 • China	Biotechnology	$3.52B	437.1	0.03%	-1.03%	vs
Zealand Pharma A/S ZEAL • Denmark	Biotechnology	$3.53B	3.5	—	-7.01%	vs
GL Galapagos NV GLPGF • United States	Biotechnology	$3.21B	0.0	—	-15.60%	vs
PH Pharmaron Beijing Co., Ltd. PHBBF • United States	Biotechnology	$3.55B	16.1	10.36%	+0.00%	vs
BioArctic AB (publ) BIOA-B • Sweden	Biotechnology	$3.19B	28.6	—	+0.06%	vs
EW Edgewise Therapeutics Inc EWTX • United States	Biotechnology	$3.17B	0.0	—	-6.56%	vs
AS Ascentage Pharma Group International ASPHF • United States	Biotechnology	$3.15B	0.0	—	+0.00%	vs
GN Genscript Biotech Corporation GNNSF • United States	Biotechnology	$3.10B	—	—	+0.00%	vs
Alumis Inc ALMS • United States	Biotechnology	$3.09B	0.0	—	+3.60%	vs
26 TransThera Sciences (Nanjing) 2617 • Hong Kong	Biotechnology	$3.07B	0.0	—	-12.79%	vs
CA Camurus AB CAMX • Sweden	Biotechnology	$3.69B	46.2	—	-1.81%	vs
68 Sinocelltech Group Ltd 688520 • China	Biotechnology	$3.04B	0.0	—	-3.12%	vs

How we rank similar stocks

Similarity is scored by sector match (baseline), industry match (priority boost), log-scale market cap proximity, and valuation multiple closeness (P/E and dividend yield). Same-industry peers surface first, then nearest-size same-sector peers.

View all Healthcare stocks →